Neuro-Oncology Reviews




Volume 22 Number 11
15 June 2020




Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 11, 15 June





*

Cooney TM, Cohen KJ, Guimaraes CV, Dhall G, Leach J, Massimino M, Erbetta A, Chiapparini L, Malbari F, Kramer K, Pollack IF, Baxter P, Laughlin S, Patay Z, Young Poussaint T, Warren KE.
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol. 2020 Jun 1;21(6):e330-e336. doi: 10.1016/S1470-2045(20)30166-2. PMID: 32502459. Guidelines. ˍ



*

Erker C, Tamrazi B, Poussaint TY, Mueller S, Mata-Mbemba D, Franceschi E, Brandes AA, Rao A, Haworth KB, Wen PY, Goldman S, Vezina G, MacDonald TJ, Dunkel IJ, Morgan PS, Jaspan T, Prados MD, Warren KE.
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol. 2020 Jun 1;21(6):e317-e329. doi: 10.1016/S1470-2045(20)30173-X. PMID: 32502458. Guidelines. ˍ



*

Fangusaro J, Witt O, Hernáiz Driever P, Bag AK, de Blank P, Kadom N, Kilburn L, Lober RM, Robison NJ, Fisher MJ, Packer RJ, Young Poussaint T, Papusha L, Avula S, Brandes AA, Bouffet E, Bowers D, Artemov A, Chintagumpala M, Zurakowski D, van den Bent M, Bison B, Yeom KW, Taal W, Warren KE.
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol. 2020 Jun 1;21(6):e305-e316. doi: 10.1016/S1470-2045(20)30064-4. PMID: 32502457. Guidelines. ˍ




Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M.
Management of glioblastoma: State of the art and future directions.
CA Cancer J Clin. 2020 Jun 1;10.3322/caac.21613. doi: 10.3322/caac.21613. PMID: 32478924. Review. ˍ




Ginalis EE, Cui T, Weiner J, Nie K, Danish S.
Two-staged stereotactic radiosurgery for the treatment of large brain metastases: Single institution experience and review of literature.
J Radiosurg SBRT. 2020
[Jun 2];7(2):105-114. PMID: 33282464. Observational study, Review. ˍ




Ruggiero A, Ariano A, Triarico S, Capozza MA, Romano A, Maurizi P, Mastrangelo S, Attinà G.
Temozolomide and oral etoposide in children with recurrent malignant brain tumors.
Drugs Context. 2020 Jun 2;9:2020-3-1. doi: 10.7573/dic.2020-3-1. PMID: 32547627. Review. ˍ




Trifiletti DM, Malouff TD, McGovern SL, Weathers SP, Wang TJC, Lassman AB, Cahill DP, Shih HA, Brown PD.
Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma.
Semin Radiat Oncol. 2020 Jun 2;30(3):218-222. doi: 10.1016/j.semradonc.2020.02.005. PMID: 32503786 Review. ˍ




Yekula A, Muralidharan K, Rosh ZS, Youngkin AE, Kang KM, Balaj L, Carter BS.
Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas.
Adv Biosyst. 2020 Jun 2;e2000029. doi: 10.1002/adbi.202000029. PMID: 32484293. Review. ˍ




Lee KH, Seong HJ, Kim G, Jeong GH, Kim JY, Park H, Jung E, Kronbichler A, Eisenhut M, Stubbs B, Solmi M, Koyanagi A, Hong SH, Dragioti E, de Rezende LFM, Jacob L, Keum N, van der Vliet HJ, Cho E, Veronese N, Grosso G, Ogino S, Song M, Radua J, Jung SJ, Thompson T, Jackson SE, Smith L, Yang L, Oh H, Choi EK, Shin JI, Giovannucci EL, Gamerith G.
Consumption of Fish and ω-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies.
Adv Nutr. 2020 Jun 3;11(5):1134-1149. doi: 10.1093/advances/nmaa055. PMID: 32488249. Review, Meta-analysis. ˍ




Herbener VJ, Burster T, Goreth A, Pruss M, von Bandemer H, Baisch T, Fitzel R, Siegelin MD, Karpel-Massler G, Debatin KM, Westhoff MA, Strobel H.
Considering the Experimental use of Temozolomide in Glioblastoma Research.
Biomedicines. 2020 Jun 4;8(6):151. doi: 10.3390/biomedicines8060151. PMID: 32512726. Review. ˍ




Lassman AB, Joanta-Gomez AE, Pan PC, Wick W.
Current usage of tumor treating fields for glioblastoma.
Neurooncol Adv. 2020 Jun 4;2(1):vdaa069
. doi: 10.1093/noajnl/vdaa069. PMID: 32666048. Observational study, Meeting report. ˍ




Roth P, Hottinger AF, Hundsberger T, Läubli H, Schucht P, Reinert M, Mamot C, Roelcke U, Pesce G, Hofer S, Weller M.
A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.
Swiss Med Wkly. 2020 Jun 5;150:w20256. doi: 10.4414/smw.2020.20256. PMID: 32557428. Review. ˍ




Yu Y, Ma Y, Sun M, Jiang W, Yuan T, Tong D.
Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
Medicine (Baltimore). 2020 Jun 5;99(23):e20270. doi: 10.1097/MD.0000000000020270. PMID: 32501974. Review, Meta-analysis. ˍ




Lohmann P, Galldiks N, Kocher M, Heinzel A, Filss CP, Stegmayr C, Mottaghy FM, Fink GR, Jon Shah N, Langen KJ.
Radiomics in neuro-oncology: Basics, workflow, and applications.
Methods. 2020 Jun 6;188:112-121. doi: 10.1016/j.ymeth.2020.06.003. PMID: 32522530. Review. ˍ




Roth J, Constantini S, Cinalli G.
Neurofibromatosis type 1-related hydrocephalus: causes and treatment considerations.
Childs Nerv Syst. 2020 Jun 6;36(10):2385-2390. doi: 10.1007/s00381-020-04719-y. PMID: 32504175. Review. ˍ




Grossman SA, Romo CG, Rudek MA, Supko J, Fisher J, Nabors LB, Wen PY, Peereboom DM, Ellingson BM, Elmquist W, Barker FG, Kamson D, Sarkaria JN, Timmer W, Bindra RS, Ye X; Adult Brain Tumor Consortium.
Baseline Requirements for Novel Agents Being Considered for Phase II/III Brain Cancer Efficacy Trials: Conclusions from the Adult Brain Tumor Consortium's First Workshop on CNS Drug Delivery.
Neuro Oncol. 2020 Jun 7;22(10):1422-1424. doi: 10.1093/neuonc/noaa142. PMID: 32506123. Meeting report. ˍ




Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Jun 8. NCBI Bookshelf ID: NBK65812. PMID: 26389253. Review. ˍ




Trone JC, Vallard A, Sotton S, Ben Mrad M, Jmour O, Magné N, Pommier B, Laporte S, Ollier E.
Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis.
Radiat Oncol. 2020 Jun 8;15(1):145. doi: 10.1186/s13014-020-01584-6. PMID: 32513205. Review, Meta-analysis. ˍ




Tsang M, Cleveland J, Rubenstein JL.
On point in primary CNS lymphoma.
Hematol Oncol. 2020 Jun 8;38(5):640-647. doi: 10.1002/hon.2761. PMID: 32510610. Review. ˍ




Boxerman JL, Quarles CC, Hu LS, Erickson BJ, Gerstner ER, Smits M, Kaufmann TJ, Barboriak DP, Huang RH, Wick W, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Chung C, van den Bent MJ, Chang S, Al Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Rosen BR, Ellingson BM, Schmainda KM; Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee.
Consensus Recommendations for a Dynamic Susceptibility Contrast MRI Protocol for Use in High-Grade Gliomas.
Neuro Oncol. 2020 Jun 9;22(9):1262-1275. doi: 10.1093/neuonc/noaa141. PMID: 32516388. Guidelines. ˍ




Girardi F, Allemani C, Coleman MP.
Global Trends in Survival From Astrocytic Tumors in Adolescents and Young Adults: A Systematic Review.
JNCI Cancer Spectr. 2020 Jun 10;4(5):pkaa049. doi: 10.1093/jncics/pkaa049. PMID: 33134829. Review. ˍ




Tork CA, Atkinson C.
Oligodendroglioma.
StatPearls 2020 Jun 10. NCBI Bookshelf ID: NBK559184. PMID: 32644610. Review. ˍ




DeNunzio NJ, Yock TI.
Modern Radiotherapy for Pediatric Brain Tumors.
Cancers (Basel). 2020 Jun 11;12(6):E1533. doi: 10.3390/cancers12061533. PMID: 32545204. Review. ˍ




Cai Z, Yang S, Li X, Chen F, Li W.
Viral infection and glioma: a meta-analysis of prognosis.
BMC Cancer. 2020 Jun 12;20(1):549. doi: 10.1186/s12885-020-06796-3. PMID: 32532243. Meta-analysis. ˍ




Botros D, Dux H, Price C, Khalafallah AM, Mukherjee D.
Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review.
Neurosurg Rev. 2020 Jun 13;44(3):1259-1271. doi: 10.1007/s10143-020-01331-1. PMID: 32533385. Review. ˍ




Bajetto A, Thellung S, Dellacasagrande I, Pagano A, Barbieri F, Florio T.
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies.
Stem Cells Transl Med. 2020 Jun 15;9(11):1310-1330. doi: 10.1002/sctm.20-0161. PMID: 32543030. Review. ˍ




De Lima L, Sürme MB, Gessi M, Mastronuzzi A, Miele E, Tamburrini G, Massimi L.
Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
Childs Nerv Syst. 2020 Jun 15;36(8):1589-1599. doi: 10.1007/s00381-020-04692-6. PMID: 32542405. Review. ˍ




Grabowski MM, Sankey EW, Ryan KJ, Chongsathidkiet P, Lorrey SJ, Wilkinson DS, Fecci PE.
Immune suppression in gliomas.
J Neurooncol. 2020 Jun 15;151(1):3-12. doi: 10.1007/s11060-020-03483-y. PMID: 32542437. Review. ˍ




Kirby AJ, Finnerty GT.
New strategies for managing adult gliomas.
J Neurol. 2020 Jun 15;268(10):3666-3674. doi: 10.1007/s00415-020-09884-3. PMID: 32542524. Review. ˍ




Majc B, Sever T, Zarić M, Breznik B, Turk B, Lah TT.
Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment.
Biochim Biophys Acta Mol Cell Res. 2020 Jun 15;1867(10):118782. doi: 10.1016/j.bbamcr.2020.118782. PMID: 32554164. Review. ˍ




Raviraj R, Nagaraja SS, Selvakumar I, Mohan S, Nagarajan D.
The epigenetics of brain tumors and its modulation during radiation: A review.
Life Sci. 2020 Jun 15;256:117974. doi: 10.1016/j.lfs.2020.117974. PMID: 32553924. Review. ˍ




Soldozy S, Skaff A, Soldozy K, Sokolowski JD, Norat P, Yagmurlu K, Sharifi KA, Tvrdik P, Park MS, Kalani MYS, Jane JA, Syed HR.
From Bench to Bedside, the Current State of Oncolytic Virotherapy in Pediatric Glioma.
Neurosurgery. 2020 Jun 15;87(6):1091-1097. doi: 10.1093/neuros/nyaa247. PMID: 32542365. Review. ˍ




Walsh KM.
Epidemiology of meningiomas.
Handb Clin Neurol. 2020 Jun 15;169:3-15. doi: 10.1016/B978-0-12-804280-9.00001-9. PMID: 32553297. Review. ˍ